Doing well by doing good

Research output: Contribution to journalReview article

Abstract

Herceptin has a second act in breast cancer, but will it be too costly to deliver? An important question on quality care, addressed by several articles in this issue.

Original languageEnglish (US)
Number of pages1
JournalCommunity Oncology
Volume2
Issue number5
DOIs
StatePublished - Jan 1 2005

Fingerprint

Quality of Health Care
Breast Neoplasms
Trastuzumab

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Doing well by doing good. / Schwartzberg, Lee.

In: Community Oncology, Vol. 2, No. 5, 01.01.2005.

Research output: Contribution to journalReview article

@article{3b576d8ff58543999c6b0a19f7fa55df,
title = "Doing well by doing good",
abstract = "Herceptin has a second act in breast cancer, but will it be too costly to deliver? An important question on quality care, addressed by several articles in this issue.",
author = "Lee Schwartzberg",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/S1548-5315(11)70609-X",
language = "English (US)",
volume = "2",
journal = "Community Oncology",
issn = "1548-5315",
publisher = "BioLink Communications",
number = "5",

}

TY - JOUR

T1 - Doing well by doing good

AU - Schwartzberg, Lee

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Herceptin has a second act in breast cancer, but will it be too costly to deliver? An important question on quality care, addressed by several articles in this issue.

AB - Herceptin has a second act in breast cancer, but will it be too costly to deliver? An important question on quality care, addressed by several articles in this issue.

UR - http://www.scopus.com/inward/record.url?scp=25444486977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444486977&partnerID=8YFLogxK

U2 - 10.1016/S1548-5315(11)70609-X

DO - 10.1016/S1548-5315(11)70609-X

M3 - Review article

VL - 2

JO - Community Oncology

JF - Community Oncology

SN - 1548-5315

IS - 5

ER -